BAYLOR COLLEGE OF MEDICINE;OPEXA PHARMACEUTICALS INC.
发明人:
ZHANG JINGWU Z.
申请号：
PL37472303
公开号：
PL213315B1
申请日:
2003.06.05
申请国别(地区):
PL
年份:
2013
代理人:
摘要：
The present invention relates generally to the field of treating autoimmune diseases, such as multiple sclerosis (MS), rheumatoid arthritis (RA) and others. Methods of treating and monitoring an autoimmune disease by utilizing T-cell receptors peptides are disclosed. Nucleic acid and peptide sequences of T-cell receptors found in a population of MS patients are also disclosed.
